Tag: therapeutice

46 PALLETS 4178 CARTONS PH ARMACEUTICALS AS UNDER ONDA NSETRON ODT 4MG 30UD NDC CODE :68462015713 FDA PRODUCT CODE NO,:-61 T C A 26 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-152 THERAPEUTICE USE:-ANTI MRFU0016168 001 -EMETIC ONDANSETRON TAB 8M G 30 NDC CODE:68462010630 FD A PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUT ICE USE:-ANTI -EMETIC OXCA RBAZEPINE TAB 600MG 100 NDC C ODE:68462013901 FDA PRODUCT C MRFU0016168 001 ODE NO.:-61 M C A 45 HTS NO. 3004.90.9236 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONV ULSANT AGENT CLOTRIMAZOLE C REAM 1% 45GM NDC CODE:6846201 8147 FDA PRODUCT CODE NO :61 W C J 04 HTS NO.3004.90.9240 ANDA NO.90-219 THERAPEUTICE MRFU0016168 001 USE:-TREATMENT OF CANDIDIAS IS IMIQUIMOD CREAM 5% 0.25G M 24 NDC CODE:68462053670 FD A PRODUCT CODE NO.: 62 V C J 29 H. T. S NO.: 3004.49.00.5 0 ANDA NO.:201994 THERAPEUTI CE USE: - INDICATED FOR ACTIN IC KERATOSES AND EXTERNAL GE MRFU0016168 001 NITAL AND PERIANAL WARTS T ELMISARTAN TAB 40MG 30 NDC CO DE:68462020030 FDA PRODUCT CO DE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 090032 THERAPEUTICE USE: IND ICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD MRFU0016168 001 PRESSURE ONDANSETRON TAB 8M G 30 NDC CODE:68462010630 FD A PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUT ICE USE:-ANTI -EMETIC COMM ERCIAL & CUSTOM INVOICE NO. F 22552001328 DT. 21.06.2024 F2 MRFU0016168 001 2552001331 DT. 21.06.2024 F22 552001336 DT. 21.06.2024 S/BI LL NO:1851894 DT 21-JUN-2024 S/BILL NO:1851900 DT 21-JUN-20 24 S/BILL NO:1853409 DT 21-JU N-2024 NET WT. 7258.043 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE MRFU0016168 001 S TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A

41 PALLETS 3129 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 12.5MG 100 NDC COD E:68462016401 FDA PRODUCT COD E NO :62 O C A 22 HTS NO.300 4.90.9221 ANDA NO.78-251 THE RAPEUTICE USE:-BETA- ADRENOA MNBU0552050 001 CEPTOR ANTAGONIST TELMISAR TAN-HCTZ TAB 80MG/25MG 30UD N DC CODE:68462084213 62 O D A 09 3004.90.92.20 202544 TEL MISARTAN AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED FOR THE TREATMENT OF HYPERTENS ION, TO LOWER BLOOD PRESSURE. MNBU0552050 001 TOPIRAMATE ER CAP (Q) 200M G 30 NDC CODE:68462037130 30 04.49.00.20 61 M C B 40 2102 78 COLESEVELAM HCL TAB 625M G 180 NDC CODE:68462043318 F DA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00. 10 ANDA NO.: 203480 THERAPEU MNBU0552050 001 TICE USE: - ANTIHYPERLIPO PR OTEINEMIC. TELMISARTAN-HCTZ TAB 80MG/12.5MG 30UD NDC COD E:68462084113 62 O D A 09 30 04.90.92.20 202544 TELMISART AN AND HYDROCHLOROTHIAZIDE T ABLETS ARE INDICATED FOR THE TREATMENT OF HYPERTENSION, T MNBU0552050 001 O LOWER BLOOD PRESSURE. CA RVEDILOL TAB 12.5MG 500 NDC C ODE:68462016405 FDA PRODUCT C ODE NO :62 O C A 22 HTS NO.3 004.90.9221 ANDA NO.78-251 T HERAPEUTICE USE:-BETA- ADREN OACEPTOR ANTAGONIST SEVELA MER HCL TAB 800MG 180 NDC COD MNBU0552050 001 E:68462044718 FDA PRODUCT COD E NO.: 63 L D A 04 H. T. S N O.: 3004.90.92.60 ANDA NO.:2 04724 THERAPEUTICE USE:SEVEL AMER HYDROCHLORIDE TABLETS A RE A PHOSPHATE BINDER INDICAT ED FOR THE CONTROL OF SERUM P HOSPHORUS IN PATIENTS WITH CH MNBU0552050 001 RONIC KIDNEY DISEASE ON DIAL YSIS DILTIAZEM HCL ER CAP 1 2HR 90MG 100 NDC CODE:6846208 5101 62 O C B 24 3004.49.00. 10 212317 FOR THE TREATMENT OF HYPERTENSION. TACROLIMU S OINT 0.1% 60GM NDC CODE:684 62053465 FDA PRODUCT CODE NO. MNBU0552050 001 : 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 21039 3 THERAPEUTICE USE: - TACROL IMUS IS A TOPICAL IMMUNOSUPPR ESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEV ERE ATOPIC DERMATITIS (ECZEM A). PIMECROLIMUS CREAM 1% 6 MNBU0552050 001 0GM NDC CODE:68462060965 FDA PRODUCT CODE NO.: 61 S C J 0 4 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTI CE USE: - AS SECOUND-LINE THE RAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTME NT OF MILD TO MODERATE ATOPIC MNBU0552050 001 DERMATITIS IN NONIMMUNOCOMP ROMISED ADULT AND CHILDREN 2 YEARS OF AGE SIROLIMUS TAB 1MG 100 NDC CODE:68462068301 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90. 92.15 ANDA NO.: 208691 THERA PEUTICE USE: TO PREVENT REJEC MNBU0552050 001 TION OF KIDNEY TRANSPLANTS. PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FDA PROD UCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C MNBU0552050 001 ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NONIMMUNOCOMPROMIS ED ADULT AND CHILDREN 2 YEAR S OF AGE COMMERCIAL & CUSTO M INVOICE NO. F22587000467 DT . 19.06.2024 F22587000468 DT. 19.06.2024 F22587000469 DT. MNBU0552050 001 19.06.2024 F22587000470 DT. 1 9.06.2024 F22587000471 DT. 19 .06.2024 S/BILL NO: 4010175 D T:20/06/2024 S/BILL NO: 40101 73 DT:20/06/2024 S/BILL NO: 4 010169 DT:20/06/2024 S/BILL N O: 4010170 DT:20/06/2024 S/BI LL NO: 4010172 DT:20/06/2024 MNBU0552050 001 NET WT. 6362.223 KGS 02 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA

DROSPIRENONE/EE TAB 1963 CARTONS PHARMACEUTICALS AS UNDER DROSPIRENONE/EE TAB 3/0.03MG 84 NDC CODE 68462073329 FDA PRODUCT CODE NO. HLBU9708084 001 65 J D A 39 H. T. S NO. 3006.60.00.00 ANDA NO. 204848 THERAPEUTICE USE - CONTRACEPTION TO PREVENT PREGNANCY NORETH ACE/EE TAB HLBU9708084 001 1/0.02MG 63 NDC CODE 68462013281 FDA PRODUCT CODE NO. 65 J C A 25 H. T. S NO. 3006.60.00.00 ANDA NO. 206969 THERAPEUTICE USE - HLBU9708084 001 SECONDARY AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL & CUSTOM INVOICE NO. F22552001238 DT. 17.06.2024 F22552001246 DT. 17.06.2024 HLBU9708084 001 S/BILL NO 1751842 DT 18-JUN-2024 S/BILL NO 1751845 DT 18-JUN-2024 GROSS WT. 5,690.760 KGS NET WT. 4168.970 KGS HBL NO BOM0064350 SCAC CODE YASV HLBU9708084 001 02 DATA LOGGERS HUMIDITY 65% TEMPERATURE RANGE +15 DEGREES TO +25 DEGREES

KIND OF PACKAGES, DESCRIPTION OF GOODS, MARKS AND NUMBERS, CONTAINER NOS SEAL NO. PHARMAC EUTICALS AS UNDER OMEPRAZOLE DR CAP 40MG 1 000 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO.:91 672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE OXCARBAZE HLBU9593391 001 PINE TAB 300MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004. 90.9236 ANDA NO.:-77-802 THERAPEUTICE USE:- ANTI CONVULSANT AGENT GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 FDA PRODUCT COD E:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSA NT 02 DATA LOGGERS HUMIDITY:65% S HLBU9593391 001 ET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREES CONTAINER NO . HLBU9593391

GABAPENTIN TAB 3236 CARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 600MG 500 NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69 HLBU9972857 001 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT URSODIOL TAB 250MG 100 NDC CODE 68462047301 FDA PRODUCT CODE NO. 63 N C A 25 HLBU9972857 001 H. T. S NO. 3004.49.00.10 ANDA NO. 90-801 THERAPEUTICE USE - FOR THE TREATMENT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS" ROPINIROLE TAB 4MG 100 HLBU9972857 001 NDC CODE 68462025801 FDA PRODUCT CODE NO. -62 J C A 17 H. T. S NO. 3004.90.92.40 ANDA NO. - 90-135 THERAPEUTICE USE -TREATMENT OF HLBU9972857 001 PARKINSONISM ROPINIROLE TAB 5MG 100 NDC CODE 68462025901 FDA PRODUCT CODE NO. 62 J C A 17 H. T. S NO. 3004.90.92.40 ANDA NO. - 90-135 HLBU9972857 001 THERAPEUTICE USE -TREATMENT OF PARKINSONISM TROSPIUM CL TAB 20MG 60 NDC CODE 68462046160 FDA PRODUCT CODE NO. -61 K C A 69 H. T. S NO. HLBU9972857 001 3004.49.00.70 ANDA NO. -91-575 THERAPEUTICE USE - TREATMENT OF VENOUS DISEASES URINARY INCONTINENCE THERAPY OXCARBAZEPINE TAB HLBU9972857 001 150MG 100 NDC CODE 68462013701 FDA PRODUCT CODE NO. -61 M C A 45 HTS NO.3004.90.9236 ANDA NO. -77-802 THERAPEUTICE USE -ANTI CONVULSANT AGENT HLBU9972857 001 METRONIDAZOLE VAG GEL 0.75% 70GM NDC CODE 68462018449 FDA PRODUCT CODE NO. 62 L C J 40 H. T. S NO. 3004.90.92.45 ANDA NO. 215794 HLBU9972857 001 THERAPEUTICE USE METRONIDAZOLE VAGINAL GEL IS INDICATED IN THE TREATMENT OF BACTERIAL VAGINOSIS (FORMERLY REFERRED TO AS HAEMOPHILUS VAGINITIS, GARDNERELLA HLBU9972857 001 VAGINITIS, NONSPECIFIC VAGINITIS, CORYNEBACTERIUM VAGINITIS, OR ANAEROBIC VAGINOSIS). CARVEDILOL TAB 6.25MG 500 NDC CODE 68462016305 FDA PRODUCT CODE NO HLBU9972857 001 62 O C A 22 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE

PHARMACEUTICAL 1957 CARTONS PHARMACEUTICALS AS UNDER HEATHER TAB 0.35MG 84 NDC CODE 68462030329 FDA PRODUCT CODE NO. 65 J C A 24 HLBU9323903 001 H. T. S NO. 3006.60.00.00 ANDA NO. 90-454 THERAPEUTICE USE PREVENTION OF PREGNANCY. DROSPIRENONE/EE TAB 3/0.03MG 84 NDC CODE 68462073329 HLBU9323903 001 FDA PRODUCT CODE NO. 65 J D A 39 H. T. S NO. 3006.60.00.00 ANDA NO. 204848 THERAPEUTICE USE - CONTRACEPTION TO PREVENT HLBU9323903 001 PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22552001218 DT.15.06.2024 F22552001237 DT.17.06.2024 S/BILL NO 1730918 DT 17-JUN-2024 S/BILL NO 1730932 HLBU9323903 001 DT 17-JUN-2024 GROSS WT. 5,094.970 KGS NET WT.3482.520 KGS HBL NO BOM0064315 SCAC CODE YASV 02 DATA LOGGERS HUMIDITY 65%

42 PALLETS 1459 CARTONS PH ARMACEUTICALS AS UNDER FLUC ONAZOLE TAB 150MG 12UD NDC CO DE:68462011944 NDC CODE : 68 462011944 HTS NO : 3004.90.92 .45 FDA CODE : 61 W C A 45 A NDA NO. : 77 - 253 THERAPEUTI MNBU0335986 001 CE USE : ANTIFUNGAL OMEPRA ZOLE DR CAP 40MG 90 NDC CODE: 68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9 255 ANDA NO.:91672 THERAPEUT ICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISE ASE OMEPRAZOLE DR CAP 40MG MNBU0335986 001 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO.:916 72 THERAPEUTICE USE: -TREATM ENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F225520 01180 DT. 12.06.2024 F2255200 MNBU0335986 001 1181 DT. 12.06.2024 S/BILL N O:1641662 DT 13-JUN-2024 S/BI LL NO:1641646 DT 13-JUN-2024 NET WT. 4814.363 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL MNBU0335986 001 ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA

1 CONT. 40'X9'6" REEFER CONTAINER SLAC HLBU 9292417 44 PACKAGES 12171.226 SEAL: 3377 CA RTONS KGS HLG9011556 PHARMACEUTICALS AS UNDE R MARKS & NOS: CARGO TELMISARTAN TAB 80MG 30 DESCRIPTION NDC CODE:68462020130 FLO W TO THE HEART HTS NO : 3004.90.92.20 OMEPRA ZOLE DR CAP FDA CODE : 62 O C A 09 20MG 100 HLBU9292417 001 NDC ANDA NO.: 90032 CODE:68462039601 THERAPE UTICE USE : FDA PRODUCT CODE INDICATED FOR T HE NO.:62KCF10 HTS TREATMENT OF NO.3004.90. 9255 HYPERTENSION, TO LOWER ANDA NO.:91672 B LOOD PRESSURE THERAPEUTICE USE: -TREATMENT OF TOPIRAMATE TAB 100MG 500 TREAT GASTROESOP H NDC CODE:68462010905 AGEAL REFLUX FDA PROD UCT CODE NO.:

NORETH ACE/EE TAB 1/0.02MG 63 1930 CARTONS PHARMACEUTICALS AS UNDER NORETH ACE/EE TAB 1/0.02MG 63 NDC CODE 68462013281 FDA PRODUCT CODE NO. 65 J C A 25 HLBU9168411 001 H. T. S NO. 3006.60.00.00 ANDA NO. 206969 THERAPEUTICE USE - SECONDARY AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING HLBU9168411 001 HEATHER TAB 0.35MG 84 NDC CODE 68462030329 FDA PRODUCT CODE NO. 65 J C A 24 H. T. S NO. 3006.60.00.00 ANDA NO. 90-454 THERAPEUTICE USE HLBU9168411 001 PREVENTION OF PREGNANCY. COMMERCIAL & CUSTOM INVOICE NO. F22552001186 DT. 13.06.2024 S/BILL NO 1651738 DT 13-JUN-2024 NET WT. 4046.630 KGS 02 DATA LOGGERS HLBU9168411 001 HUMIDITY 65% GROSS WT. 5,622.290 KGS NET WT. 4046.630 KGS HBL NO BOM0064249 SCAC CODE YASV

OMEPRAZOLE DR CAP 40MG 100 40 PACKAGES 2210 CARTONS PHARMACEUTICALS AS UNDER OMEPRAZOLE DR CAP 40MG 100 NDC CODE 68462039701 FDA PRODUCT CODE HLBU9550419 001 NO. 61 J C A 16 H. T. S NO. 3004.49.00.10 ANDA NO. 079172 THERAPEUTICE USE - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT HLBU9550419 001 CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 40MG 500 NDC CODE 68462026405 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, HLBU9550419 001 AND TO PREVENT CARDIOVASCULAR DISEASE ACYCLOVIR OINT 5% 30GM NDC CODE 68462074635 FDA PRODUCT CODE NO. 62 V C J 18 H. T. S NO. 3004.49.00.50 HLBU9550419 001 ANDA NO. 205510 THERAPEUTICE USE - AN ANTIVIRAL MEDICINE USED TO TREAT OR PREVENT INFECTIONS CAUSED BY CERTAIN KINDS OF VIRUSES. EXAMPLES OF THESE INFECTIONS INCLUDE HERPES AND SHINGLES HLBU9550419 001 COMMERCIAL & CUSTOM INVOICE NO. F22552001163 DT. 11.06.2024 F22552001165 DT. 11.06.2024 S/BILL NO 1618657 DT 12-JUN-2024 S/BILL NO 1618665 DT 12-JUN-2024 HLBU9550419 001 GROSS WT. 877.550 KGS NET WT. 703.01 KGS SCAC CODE YASV HBL NO BOM0064212 04 DATA LOGGERS HUMIDITY 65% HLBU9550419 002 NO. 62KCF10 HTS NO.3004.90.9255 ANDA NO. 91672 THERAPEUTICE USE -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE VERAPAMIL HCL ER TAB 240MG 100 HLBU9550419 002 NDC CODE 68462026001 NDC NO. 68462026001 FDA PRODUCT CODE NO. 62 O C B 13 HTS NO.3004.90.9221 ANDA NO. 090700 THERAPEUTICE USE --ANGINA HLBU9550419 002 VERAPAMIL HCL ER TAB 240MG 500 NDC CODE 68462026005 NDC NO. 68462026005 FDA PRODUCT CODE NO. 62 O C B 13 HTS NO.3004.90.9221 ANDA NO. 090700 THERAPEUTICE USE HLBU9550419 002 --ANGINA OMEPRAZOLE DR CAP 40MG 90 NDC CODE 68462039790 FDA PRODUCT CODE NO. 62KCF10 HTS NO.3004.90.9255 ANDA NO. 91672 THERAPEUTICE USE HLBU9550419 002 -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 40MG 1000 NDC CODE 68462039710 FDA PRODUCT CODE NO. 62KCF10 HTS NO.3004.90.9255 HLBU9550419 002 ANDA NO. 91672 THERAPEUTICE USE -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 40MG 90 NDC CODE 68462039790 FDA PRODUCT CODE HLBU9550419 002 NO. 62KCF10 HTS NO.3004.90.9255 ANDA NO. 91672 THERAPEUTICE USE -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & HLBU9550419 002 CUSTOM INVOICE NO. F22552001167 DT. 12.06.2024 F22552001171 DT. 12.06.2024 S/BILL NO 1618670 DT 12-JUN-2024 S/BILL NO 1618672 DT 12-JUN-2024 GROSS WT. 10,292.348 KGS HLBU9550419 002 NET WT. 8659.736 KGS SCAC CODE YASV HBL NO BOM0064216 02 DATA LOGGERS HUMIDITY 65%

PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 10MG 90 NDC CODE:68462026290 FDA PRODUCT CO DE NO.:61 J C A 16 H. T. S NO.: 3004.49.00 .10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITI ONS, AND TO PREVENT CARDIOVASCULAR DISEASE null

NORETHINDRONE TAB 0.35MG 40 PACKAGES 1951 CARTONS PHARMACEUTICALS AS UNDER NORETHINDRONE TAB 0.35MG 84 NDC CODE 68462030529 FDA PRODUCT CODE NO. 65 J C A 26 HLBU9721487 001 H. T. S NO. 3006.60.00.00 ANDA NO. 91-209 THERAPEUTICE USE PREVENTION OF PREGNANCY. NORETH ACE/EE TAB 1/0.02MG 63 NDC CODE 68462013281 FDA PRODUCT CODE HLBU9721487 001 NO. 65 J C A 25 H. T. S NO. 3006.60.00.00 ANDA NO. 206969 THERAPEUTICE USE - SECONDARY AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE HLBU9721487 001 BLEEDING COMMERCIAL & CUSTOM INVOICE NO. F22552001139 DT. 10.06.2024 F22552001147 DT. 10.06.2024 S/BILL NO 1568595 DT 10-JUN-2024 S/BILL NO 1567800 HLBU9721487 001 DT 10-JUN-2024 GROSS WT. 5,727.440 KGS NET WT. 4178.180 KGS HBL NO BOM0064170 SCAC CODE YASV 02 DATA LOGGERS HUMIDITY 65%

45 PALLETS 1978 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 40MG 1000 NDC C ODE:68462039710 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR MNBU0578179 001 EAT GASTROESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 25MG 500 NDC CODE:68462010805 FD A PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:077627 THERAPEUTI CE USE: ANTICONVULSANT TOP IRAMATE TAB 25MG 500 NDC CODE MNBU0578179 001 :68462010805 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO .: 3004.49.00.20 ANDA NO.:07 7627 THERAPEUTICE USE: ANTIC ONVULSANT TOPIRAMATE TAB 25 MG 1000 NDC CODE:68462010810 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.0 MNBU0578179 001 0.20 ANDA NO.:- 77-627 THERA PEUTICE USE:-ANTICONVULSANT TOPIRAMATE TAB 100MG 60 NDC CODE:68462010960 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA N O.:- 77-627 THERAPEUTICE USE :-ANTICONVULSANT OMEPRAZOLE MNBU0578179 001 DR CAP 20MG 1000 NDC CODE:68 462039610 FDA PRODUCT CODE N O.:62KCF10 HTS NO.3004.90.925 5 ANDA NO.:91672 THERAPEUTIC E USE: -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E MUPIROCIN CREAM 2% 15GM NDC CODE:68462056417 FDA PROD MNBU0578179 001 UCT CODE NO.: 61GCJ82 H. T. S NO.: 3004.90.92.45 ANDA NO .: 201587 THERAPEUTICE USE: - TOPICAL ANTI-BACTERIAL MU PIROCIN OINT 2% 22GM NDC CODE :68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO .: 3004.90.92.45 ANDA NO.: 9 MNBU0578179 001 0-480 THERAPEUTICE USE: - AN TI-BACTERIAL MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 90-480 THERA PEUTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOIC MNBU0578179 001 E NO. F22552000892 DT. 29.05. 2024 F22552000938 DT. 30.05.2 024 F22552001038 DT. 31.05.20 24 F22552001016 DT. 31.05.202 4 F22552001017 DT. 31.05.2024 F22552001033 DT. 31.05.2024 S/BILL NO: 1361097 DT 01-JUN- 2024 S/BILL NO: 1361435 DT 01 MNBU0578179 001 -JUN-2024 S/BILL NO: 1365596 DT 01-JUN-2024 S/BILL NO: 136 1434 DT 01-JUN-2024 S/BILL NO : 1361106 DT 01-JUN-2024 S/BI LL NO: 1361105 DT 01-JUN-2024 NET WT. 7983.030 KGS 02 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE MNBU0578179 001 RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA

4 PALLETS 480 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 40MG 30 NDC CODE:6 8462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 0791 72 THERAPEUTICE USE: - TO TR MCAU6001040 001 EAT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVEN T CARDIOVASCULAR DISEASE C OMMERCIAL & CUSTOM INVOICE NO. F22587000338 DT. 31.05.2024 S/BILL NO:4009345 DT: 05/06/2 024 NET WT. 729.61 KGS 04 D ATA LOGGERS HUMIDITY:65% SET MCAU6001040 001 TEMPERATURE : +18 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERL AND

46 PALLETS 3105 CARTONS PH ARMACEUTICALS AS UNDER MUPI ROCIN CREAM 2% 30GM NDC CODE: 68462056435 FDA PRODUCT CODE NO.: 61GCJ82 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 201587 THERAPEUTICE USE: - TOPICAL MNBU0592053 001 ANTI-BACTERIAL ATOVAQUONE- PROG TAB 62.5/25MG 100 NDC CO DE:68462040201 FDA PRODUCT CO DE NO.: 62 L D A 44 H. T. S NO.: 3004.90.92.90 ANDA NO.: 91-211 ANTI MALARIAL TOPI RAMATE TAB 25MG 60 NDC CODE:6 8462010860 FDA PRODUCT CODE MNBU0592053 001 NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77 -627 THERAPEUTICE USE:-ANTIC ONVULSANT NAPROXEN TAB 500M G 100 NDC CODE:68462019001 F DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU MNBU0592053 001 TICE USE:-ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 250 MG 100 NDC CODE:68462018801 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92 .40 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 50 MNBU0592053 001 0MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAP EUTICE USE:-ANTI-INFLAMMATORY , ANALGESIC NAPROXEN TAB 5 00MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G MNBU0592053 001 C A 49 H. T. S NO.: 3004.90. 92.40 ANDA NO.:-78-250 THERA PEUTICE USE:-ANTI-INFLAMMATOR Y, ANALGESIC OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462 039610 FDA PRODUCT CODE NO.: 62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE U MNBU0592053 001 SE: -TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 50MG 60 NDC CODE:68462015360 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO .:- 77-627 THERAPEUTICE USE: -ANTICONVULSANT COMMERCIAL MNBU0592053 001 & CUSTOM INVOICE NO. F2255200 1030 DT. 31.05.2024 F22552000 961 DT. 31.05.2024 F225520009 93 DT. 31.05.2024 F2255200101 0 DT. 31.05.2024 F22552001048 DT. 31.05.2024 F22552001039 DT. 31.05.2024 F22552001042 D T. 31.05.2024 S/BILL NO: 1426 MNBU0592053 001 146 DT 04-JUN-2024 S/BILL NO: 1426563 DT 04-JUN-2024 S/BIL L NO: 1426562 DT 04-JUN-2024 S/BILL NO: 1426456 DT 04-JUN-2 024 S/BILL NO: 1426458 DT 04- JUN-2024 S/BILL NO: 1426341 D T 04-JUN-2024 S/BILL NO: 1426 332 DT 04-JUN-2024 NET WT:950 MNBU0592053 001 1.728 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

11 PALLETS 766 CARTONS PHARM ACEUTICALS AS UNDER NAPROXEN TAB 500MG 100 NDC CODE:684620 19001 FDA PRODUCT CODE NO.:- 62 G C A 49 H. T. S NO.: 300 4.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAM MNBU0609114 001 MATORY, ANALGESIC NAPROXEN T AB 500MG 500 NDC CODE:6846201 9005 FDA PRODUCT CODE NO.:-6 2 G C A 49 H. T. S NO.: 3004 .90.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFLAMM ATORY, ANALGESIC TOPIRAMATE TAB 25MG 60 NDC CODE:68462010 MNBU0609114 001 860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:- 77-627 T HERAPEUTICE USE:-ANTICONVULSA NT COMMERCIAL & CUSTOM INVOIC E NO. F22552001065 DT. 03.06. 2024 F22552001066 DT. 03.06.2 024 S/BILL NO: 1420490 DT 04- MNBU0609114 001 JUN-2024 S/BILL NO: 1424108 D T 04-JUN-2024 NET WT. 2176.21 3 KGS 03 DATA LOGGERS NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA

46 PALLETS 3201 CARTONS PH ARMACEUTICALS AS UNDER ROPI NIROLE TAB 0.5MG 100 NDC CODE :68462025401 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE MCAU6028329 001 ATMENT OF PARKINSONISM TOP IRAMATE TAB 25MG 60 NDC CODE: 68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:- 7 7-627 THERAPEUTICE USE:-ANTI CONVULSANT ROPINIROLE TAB 1 MG 100 NDC CODE:68462025501 MCAU6028329 001 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92 .40 ANDA NO.:- 90-135 THERAP EUTICE USE:-TREATMENT OF PAR KINSONISM LEVOCETIRIZINE DI HY TAB 5MG 90 NDC CODE:684620 34690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 300 MCAU6028329 001 4.90.91.80 ANDA NO.:90385 TH ERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICARIA OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PR ODUCT CODE NO.:62KCF10 HTS N O.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMEN MCAU6028329 001 T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE LITHIUM CARB CAP 600MG 100 NDC CODE:68462 022201 FDA PRODUCT CODE NO.: -61 N C E 37 H. T. S NO.: 30 04.49.00.20 ANDA NO.:- 79 -13 9 THERAPEUTICE USE:-ANTIMANI C AGENT VERAPAMIL HCL ER TA MCAU6028329 001 B 180MG 100 NDC CODE:68462029 301 NDC NO.: 68462029301 FDA PRODUCT CODE NO.: 62 O C B 1 3 HTS NO.3004.90.9221 ANDA N O.: 090700 THERAPEUTICE USE: --ANGINA VERAPAMIL HCL ER TAB 180MG 500 NDC CODE:684620 29305 NDC NO.: 68462029305 F MCAU6028329 001 DA PRODUCT CODE NO.: 62 O C B 13 HTS NO.3004.90.9221 ANDA NO.: 090700 THERAPEUTICE USE : --ANGINA MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 90-480 THERAP MCAU6028329 001 EUTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO. F22552001086 DT. 05.06.2 024 F22552001085 DT. 05.06.20 24 F22552001087 DT. 05.06.202 4 F22552001082 DT. 05.06.2024 S/BILL NO: 1480014 DT 06-JUN -2024 S/BILL NO: 1479656 DT 0 MCAU6028329 001 6-JUN-2024 S/BILL NO: 1479659 DT 06-JUN-2024 S/BILL NO: 14 79664 DT 06-JUN-2024 NET WT. 8552.560 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK P MCAU6028329 001 HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA

RYALTRIS 56 MD US 1X40RF CONTAINING 15 PALLETS CONTAINING 255 CARTONS PHARMACEUTICALS AS UNDER RYALTRIS 56 MD US NDC CODE 59467070084 HLBU9156982 001 FDA PRODUCT CODE NO. 64 G C A 29 H. T. S NO. 3004.90.9270 ANDA NO. 211746 THERAPEUTICE USE INDICATEDFOR THE TREATMENT OF SYMPTOMS HLBU9156982 001 ASSOCIATED WITH ALLERGIC RHINITIS AND RHINOCONJUNCTIVITIS 15 DATA LOGGERS COMMERCIAL & CUSTOM INVOICE NO. F22500000267 DT. 16.05.2024 SB NO. 9934043 DT. 16.05.2024 HLBU9156982 001 NET WEIGHT 1690.59 KGS FREIGHT PREPAID NOTIFY PARTY 2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND HLBU9156982 001 XGST NO. 27AAACG2207L1ZS XXEMAIL HIKMASEKOLOGISTICS.COM

PHARMACEUTICALS 1X40RF CONTAINING 16 PALLETS CONTAIN 277 CARTONS PHARMACEUTICALS AS UNDER RYALTRIS 56 MD US NDC CODE 59467070084 HLBU9603756 001 FDA PRODUCT CODE NO. 64 G C A 29 H. T. S NO. 3004.90.9270 ANDA NO. 211746 THERAPEUTICE USE INDICATEDFOR THE TREATMENT OF SYMPTOMS HLBU9603756 001 ASSOCIATED WITH ALLERGIC RHINITIS AND RHINOCONJUNCTIVITIS 16 DATA LOGGERS HUMIDITY 65% COMMERCIAL & CUSTOM INVOICE NO. F22500000065 DT. 19.04.2024 HLBU9603756 001 NET WEIGHT 1836.45 KGS SB NO. 9254930 DT 19.04.2024 FREIGHT PREPAID XGST NO. 27AAACG2207L1ZS XXEMAIL HIKMASEKOLOGISTICS.COM

GABAPENTIN TAB 800MG 500 2273 CARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 800MG 500 NDC CODE 68462012705 FDA PRODUCT CODE NO 61 N C A 69 HLBU9292886 001 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT OMEPRAZOLE DR CAP 40MG 1000 NDC CODE 68462039710 FDA PRODUCT CODE NO. 62KCF10 HLBU9292886 001 HTS NO.3004.90.9255 ANDA NO. 91672 THERAPEUTICE USE -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE OXCARBAZEPINE TAB 150MG 100 NDC CODE 68462013701 HLBU9292886 001 FDA PRODUCT CODE NO. -61 M C A 45 HTS NO.3004.90.9236 ANDA NO. -77-802 THERAPEUTICE USE -ANTI CONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. HLBU9292886 001 F22552000136 DT. 12.04.2024 F22552000137 DT. 12.04.2024 S/BILL NO 9103933 DT 13-APR-2024 S/BILL NO 9103931 DT 13-APR-2024 GROSS WT. 14,875.719 NET WT.13407.051 HBL NO BOM0062884 SCAC CODE YASV HLBU9292886 001 02 DATA LOGGERS HUMIDITY 65%

PHARMACEUTICALS AS UNDER GABAPENTIN TAB 80 0MG 500 NDC CODE:68462012705 FDA PRODUCT C ODE:NO : 61 N C A 69 HTS NO.3004.90.9236 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVUL SANT OXCARBAZEPINE TAB 150MG 100 NDC CODE :68462013701 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO.:-77-802 T HLBU9905170 001 HERAPEUTICE USE:-ANTI CONVULSANT AGENT LE VOCETIRIZINE DIHY TAB 5MG 90 NDC CODE:684620 34690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.:90385 TH ERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPA THIC URTICARIA NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA N HLBU9905170 001 O.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMAT ORY, ANALGESIC CLOTRIMAZOLE CREAM 1% 15GM NDC CODE:68462018117 FDA PRODUCT CODE NO :61 W C J 04 HTS NO.3004.90.9240 ANDA NO.90 -219 THERAPEUTICE USE:-TREATMENT OF CANDID IASIS NORGEST/EE TAB 0.25/0.035MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO HLBU9905170 001 .: 200538 THERAPEUTICE USE: - ORAL CONTRACE PTIVES NORETHINDRONE ACE TAB 5MG 50 NDC C ODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.:- 91-090 THERAPEUTICE USE:- SECONDARY AMENOR RHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BL EEDING 03 DATA LOGGERS HUMIDITY:65 % SET TEMPERATURE : +20 DEGREES TEMPERATURE HLBU9905170 001 RANGE : +15 DEGREES TO +25 DEGREES CONTAINE R NO. HLBU9905170 COMMERCIAL & CUSTOM INVOICE NO. F22552000141 DT. 12.04.2024 F2 2552000143 DT. 12.04.2024 F22552000144 DT. 1 2.04.2024 F22552000142 DT. 12.04.2024 F2255 2000140 DT. 12.04.2024 F22552000145 DT. 12.0 4.2024

41 PALLETS 1979 CARTONS PH ARMACEUTICALS AS UNDER LEVO NORGESTREL/EE TAB 0.09/0.02MG 84 NDC CODE:68462063729 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 202791 THERAPEUTICE MNBU0583447 001 USE: - : USED FOR PREVENTING PREGNANCY NORETH ACE/EE T AB 1/0.02MG 63 NDC CODE:68462 013281 FDA PRODUCT CODE NO.: 65 J C A 25 H. T. S NO.: 300 6.60.00.00 ANDA NO.:206969 T HERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOMETRIOS IS AN MNBU0583447 001 D ABNORMAL UTERINE BLEEDING NORETH ACE/EE TAB 0.5MG/2.5M CG 84 NDC CODE:68462065629 F DA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.: 203038 THERAPEU TICE USE: - TREATMENT OF MODE RATE TO SEVERE VASOMOTOR SYM MNBU0583447 001 PTOMS DUE TO MENOPAUSE; OSTE OPOROSIS PREVENTION COMMERC IAL & CUSTOM INVOICE NO. F225 52000047 DT. 06.04.2024 S/BIL L NO: 8975026 DT 08-APR-2024 NET WT.4,184.73 02 DATA LOGG ERS SET TEMPERATURE : +20 D EGREES NOTIFY PARTY:2 GLEN MNBU0583447 001 MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

NAPROXEN TAB 500MG 500 48 PACKAGES 1571 CARTONS PHARMACEUTICALS AS UNDER MUPIROCIN OINT 2% 22GM NDC CODE 68462018022 FDA PRODUCT CODE NO. 61 G J J 81 HLBU9635619 001 H. T. S NO. 3004.90.92.45 ANDA NO. 90-480 THERAPEUTICE USE - ANTI-BACTERIAL OMEPRAZOLE DR CAP 40MG 1000 NDC CODE 68462039710 FDA PRODUCT CODE HLBU9635619 001 NO. 62KCF10 HTS NO.3004.90.9255 ANDA NO. 91672 THERAPEUTICE USE -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 25MG 500 HLBU9635619 001 NDC CODE 68462010805 FDA PRODUCT CODE NO. 61 M C A 40 H. T. S NO. 3004.49.00.20 ANDA NO. 077627 THERAPEUTICE USE ANTICONVULSANT HLBU9635619 001 OXCARBAZEPINE TAB 150MG 100 NDC CODE 68462013701 FDA PRODUCT CODE NO. -61 M C A 45 HTS NO.3004.90.9236 ANDA NO. -77-802 THERAPEUTICE USE -ANTI CONVULSANT AGENT HLBU9635619 001 NAPROXEN TAB 500MG 500 NDC CODE 68462019005 FDA PRODUCT CODE NO. -62 G C A 49 H. T. S NO. 3004.90.92.40 ANDA NO. -78-250 THERAPEUTICE HLBU9635619 001 USE -ANTI-INFLAMMATORY, ANALGESIC COMMERCIAL & CUSTOM INVOICE NO. F22552000121 DT. 11.04.2024 F22552000127 DT. 11.04.2024 F22552000128 DT. 11.04.2024 S/BILL NO 9067961 HLBU9635619 001 DT 12-APR-2024 S/BILL NO 9065879 DT 12-APR-2024 S/BILL NO 9066686 DT 12-APR-2024 HBL NO BOM0062875 SCAC CODE YASV GROSS WT. 10,681.747 KGS HLBU9635619 001 NET WT. 9071.889 KGS

44 PALLETS 2075 CARTONS PH ARMACEUTICALS AS UNDER DROS PIRENONE/EE TAB 3/0.03MG 84 N DC CODE:68462073329 FDA PRODU CT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204848 THERAPEUTICE USE MNBU0633907 001 : - CONTRACEPTION TO PREVENT PREGNANCY ESTRADIOL VAG IN SERTS 10MCG 8 NDC CODE:684620 71171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 300 6.60.00.00 ANDA NO.:210264 T HERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINITIS DUE TO MNBU0633907 001 MENOPAUSE. TELMISARTAN TAB 80MG 90 NDC CODE:68462020190 NDC NO.: 68462020190 FDA PR ODUCT CODE NO :62 O C A 09 H TS NO : 3004.90.92.20 ANDA NO .90032 THERAPEUTICE USE:-IND ICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD MNBU0633907 001 PRESSURE NAPROXEN TAB 500MG 100 NDC CODE:68462019001 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 500M G 500 NDC CODE:68462019005 F MNBU0633907 001 DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU TICE USE:-ANTI-INFLAMMATORY, ANALGESIC OMEPRAZOLE DR CA P 40MG 1000 NDC CODE:68462039 710 FDA PRODUCT CODE NO.:62K CF10 HTS NO.3004.90.9255 AND MNBU0633907 001 A NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROE SOPHAGEAL REFLUX DISEASE O MEPRAZOLE DR CAP 20MG 1000 ND C CODE:68462039610 FDA PRODUC T CODE NO.:62KCF10 HTS NO.30 04.90.9255 ANDA NO.:91672 TH ERAPEUTICE USE: -TREATMENT OF MNBU0633907 001 TREAT GASTROESOPHAGEAL REFLU X DISEASE ONDANSETRON ODT 8MG 30UD NDC CODE:68462015813 FDA PRODUCT CODE.:-61 T C A 26 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-152 THERAPEU TICE USE:-ANTI -EMETIC COM MERCIAL & CUSTOM INVOICE NO. MNBU0633907 001 F22452006425 DT. 29.03.2024 F 22452006434 DT. 29.03.2024 F2 2452006394 DT. 27.03.2024 F22 452006441 DT. 29.03.2024 F224 52006442 DT. 29.03.2024 S/BIL L NO: 8770843 DT 30-MAR-2024 S/BILL NO: 8763127 DT 30-MAR-2 024 S/BILL NO: 8763117 DT. 30 MNBU0633907 001 -MAR-2024 S/BILL NO: 8763135 DT 30-MAR-2024 S/BILL NO: 876 3126 DT 30-MAR-2024 NET WT. 6 208.81 KGS 02 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHA MNBU0633907 001 RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA

26 PALLETS 1504 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - MNBU0419069 001 TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). CLINDAMYCIN HCL C AP 150MG 100 NDC CODE:6846201 4301 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941. MNBU0419069 001 90.5000 ANDA NO.:216957 THER APEUTICE USE: :#TREATMENT OF NUMEROUS INFECTIONS, INCLUDIN G BUT NOT LIMITED TO SEPTIC EMIA,INTRAABDOMINAL INFECTION S, LOWER RESPIRATORY INFECTI ONS, GYNECOLOGICAL INFECTIONS , BONE AND JOINT INFECTIONS, MNBU0419069 001 AND SKIN AND SKIN STRUCTURE INFECTIONS POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:684620 35701 FDA PRODUCT CODE NO.:6 5 R C F 14 H. T. S NO.: 3004 .90.92.90 ANDA NO.:202868 TH ERAPEUTICE USE: - TREATMENT O R PREVENTION OF HYPOKALEMIA MNBU0419069 001 GABAPENTIN TAB 600MG 500 N DC CODE:68462012605 FDA PRODU CT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT GABAPENTIN TAB 60 0MG 500 NDC CODE:68462012605 FDA PRODUCT CODE:NO : 61 N C MNBU0419069 001 A 69 HTS NO.3004.90.9236 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT EZETIMI BE TAB 10MG 500 NDC CODE:6846 2022605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3 004.49.00.10 ANDA NO.: #07856 0 THERAPEUTICE USE: LIPID LO MNBU0419069 001 WERING AGENT GABAPENTIN TAB 600MG 500 NDC CODE:684620126 05 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT COMM ERCIAL & CUSTOM INVOICE NO. F 22487002437 DT. 31.03.2024 F2 MNBU0419069 001 2487002440 DT. 31.03.2024 F22 487002441 DT. 31.03.2024 F224 87002446 DT. 31.03.2024 F2248 7002447 DT. 31.03.2024 F22487 002449 DT. 31.03.2024 S/BILL NO: 4005655 DT: 02/04/2024 S/ BILL NO: 4005654 DT: 02/04/202 4 S/BILL NO: 4005653 DT: 02/0 MNBU0419069 001 4/2024 S/BILL NO: 4005652 DT: 02/04/2024 S/BILL NO: 400565 0 DT: 02/04/2024 S/BILL NO: 4 005649 DT: 02/04/2024 NET WT. 4339.144 KGS DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO MNBU0419069 001 RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA

46 PALLETS 4011 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 3.125MG 500 NDC CO DE:68462016205 FDA PRODUCT CO DE NO :62 O C A 22 HTS NO.30 04.90.9221 ANDA NO.78-251 TH ERAPEUTICE USE:-BETA- ADRENO MNBU0279516 001 ACEPTOR ANTAGONIST TELMISA RTAN TAB 80MG 30 NDC CODE:684 62020130 HTS NO : 3004.90.92. 20 FDA CODE : 62 O C A 09 AN DA NO.: 90032 THERAPEUTICE US E : INDICATED FOR THE TREATM ENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE ZOLMITRIPT MNBU0279516 001 AN TAB 2.5MG 6UD NDC CODE:684 62049776 FDA PRODUCT CODE NO. : 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO.: 20177 9 THERAPEUTICE USE: - ANALGE SIC/ HUMAN - RX/SINGLE INGRED IENT / PROMPT RELEASE TABLET S / ZOLMITRIPTAN (ANALGESIC) MNBU0279516 001 OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PROD UCT CODE NO.:62KCF10 HTS NO. 3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REF LUX DISEASE ROPINIROLE TAB 1MG 100 NDC CODE:68462025501 MNBU0279516 001 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90. 92.40 ANDA NO.:- 90-135 THER APEUTICE USE:-TREATMENT OF P ARKINSONISM GABAPENTIN TAB 800MG 500 NDC CODE:6846201270 5 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 MNBU0279516 001 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT GABAP ENTIN TAB 800MG 500 NDC CODE: 68462012705 FDA PRODUCT CODE :NO : 61 N C A 69 HTS NO.3004 .90.9236 ANDA NO.:-77-662 TH ERAPEUTICE USE:-ANTICONVULSAN T ACYCLOVIR OINT 5% 30GM N MNBU0279516 001 DC CODE:68462074635 FDA PRODU CT CODE NO.: 62 V C J 18 H. T. S NO.: 3004.49.00.50 ANDA NO.: 205510 THERAPEUTICE USE : - AN ANTIVIRAL MEDICINE USE D TO TREAT OR PREVENT INFECTI ONS CAUSED BY CERTAIN KINDS OF VIRUSES. EXAMPLES OF THESE MNBU0279516 001 INFECTIONS INCLUDE HERPES AN D SHINGLES ROSUVASTATIN TAB 40MG 30 NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.0 0.10 ANDA NO.: 079172 THERAP EUTICE USE: - TO TREAT HIGH C HOLESTEROL AND RELATED CONDIT MNBU0279516 001 IONS, AND TO PREVENT CARDIOV ASCULAR DISEASE ROSUVASTATI N TAB 40MG 500 NDC CODE:68462 026405 61 J C A 16 3004.49.0 0.10 79172 TO TREAT HIGH CHO LESTEROL AND RELATED CONDITIO NS, AND TO PREVENT CARDIOVAS CULAR DISEASE COMMERCIAL & MNBU0279516 001 CUSTOM INVOICE NO. F224520064 95 DT. 31.03.2024 F2255200001 5 DT. 04.04.2024 F22552000016 DT. 04.04.2024 F22552000017 DT. 04.04.2024 F22552000023 D T. 04.04.2024 F22552000018 DT . 04.04.2024 F22552000024 DT. 04.04.2024 F22552000026 DT. MNBU0279516 001 04.04.2024 S/BILL NO: 8904425 DT:04042024 S/BILL NO: 89044 27 DT:04042024 S/BILL NO: 890 4426 DT:04042024 S/BILL NO: 8 904429 DT:04042024 S/BILL NO: 8904438 DT:04042024 S/BILL N O: 8904424 DT:04042024 S/BILL NO: 8904432 DT:04042024 S/BI MNBU0279516 001 LL NO: 8904431 DT:04042024 NE T WT. 9970.203 KGS 09 DATA L OGGERS SET TEMPERATURE : +2 0 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA NOTIF Y PARTY:3 GLENMARK SPECIALTY MNBU0279516 001 S.A. SWITZERLAND (GSSA) PLAC E DU PORT 2 NEUCHATEL - 2000 SWITZERLAND

31 PALLETS 1534 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB .18,.215,.25/.035MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 2 7 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPEUTI MNBU0495135 001 CE USE: - ORAL CONTRACEPTIVES MARLISSA TAB 0.15/0.03MG 8 4 NDC CODE:68462038829 FDA P RODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 A NDA NO.: 091452 THERAPEUTICE USE: ORAL CONTRACEPTIVE CO MMERCIAL & CUSTOM INVOICE NO. MNBU0495135 001 F22452006306 DT. 23.03.2024 F22452006307 DT. 23.03.2024 S /BILL NO: 8615430 DT 25-MAR-20 24 S/BILL NO: 8615427 DT 25-M AR-2024 NET WT. 4209.120 KG S 02 DATA LOGGERS HUMIDITY: 65% SET TEMPERATURE : +20 DEG REES TEMPERATURE RANGE : +15 MNBU0495135 001 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA

40 PALLETS 2400 CARTONS PH ARMACEUTICALS AS UNDER ESTR ADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA N O.:210264 THERAPEUTICE USE:TH MNBU0478328 001 E TREATMENT OF ATROPIC VAGIN ITIS DUE TO MENOPAUSE. COM MERCIAL & CUSTOM INVOICE NO. F22452006404 DT. 28.03.2024 S /BILL NO: 8715790 DT 28-MAR-20 24 NET WT. 4665.600 KGS 02 D ATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY MNBU0478328 001 :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

26 PALLETS 3051 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 5MG 90 NDC CODE: 68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO T MNBU0427254 001 REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 79172 THERAPEUTICE USE: T MNBU0427254 001 O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE . ROSUVASTATIN TAB 40MG 500 NDC CODE:68462026405 61 J C A 16 3004.49.00.10 79172 T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR MNBU0427254 001 EVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 40MG 30 N DC CODE:68462026430 FDA PRODU CT CODE NO.:61 J C A 16 H. T . S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND MNBU0427254 001 TO PREVENT CARDIOVASCULAR DIS EASE ROSUVASTATIN TAB 5MG 1 000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 1 6 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTIC E USE: TO TREAT HIGH CHOLESTE ROL AND RELATED CONDITIONS, A MNBU0427254 001 ND TO PREVENT CARDIOVASCULAR DISEASE. COMMERCIAL & CUST OM INVOICE NO. F22452006291 D T. 22.03.2024 F22452006292 DT . 22.03.2024 S/BILL NO: 85873 72 DT 23-MAR-2024 S/BILL NO: 8587363 DT 23-MAR-2024 NET WT .4,880.88 KGS 26 DATA LOGGER MNBU0427254 001 S SET TEMPERATURE : +20 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUC HATEL - 2000 SWITZERLAND

44 PALLETS 3062 CARTONS PH ARMACEUTICALS AS UNDER TELM ISARTAN TAB 80MG 30 NDC CODE: 68462020130 HTS NO : 3004.90. 92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPEUTICE USE : INDICATED FOR THE TRE MNBU4342643 001 ATMENT OF HYPERTENSION, TO LO WER BLOOD PRESSURE ATOMOXE TINE CAP 100MG 30 NDC CODE:68 462027130 FDA PRODUCT CODE NO .: 64 UCA 99 H. T. S NO.: 3 004.90.92.90 ANDA NO.: 079019 TREATMENT OF ATTENTION - DE FICIT/HYPERACIVITY DISORDER ( MNBU4342643 001 ADHD NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PR ODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 A NDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANAL GESIC FELODIPINE ER TAB 2.5 MG 100 NDC CODE:68462023301 MNBU4342643 001 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-365 THERAPEUTIC E USE: - TREATMENT OF HYPERT ENSION GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FD A PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA MNBU4342643 001 NO.:-77-662 THERAPEUTICE USE :-ANTICONVULSANT OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68 462039710 FDA PRODUCT CODE N O.:62KCF10 HTS NO.3004.90.925 5 ANDA NO.:91672 THERAPEUTIC E USE: -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS MNBU4342643 001 E ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PRO DUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 AND A NO.: 079172 THERAPEUTICE US E: - TO TREAT HIGH CHOLESTERO L AND RELATED CONDITIONS, AN D TO PREVENT CARDIOVASCULAR D MNBU4342643 001 ISEASE CARVEDILOL TAB 6.25M G 500 NDC CODE:68462016305 F DA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST AC RLF ADAPALENE GEL 0.1 % 45GM (CURIST) NDC CODE:7255 MNBU4342643 001 9001513 FDA PRODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208108 THERAPEUTICE USE: #TOPICAL ANTI-ACNE AGENT COMMERCIAL & CUSTOM INVOICE NO. F2245200 6396 DT. 27.03.2024 F22452006 395 DT. 27.03.2024 F224520063 MNBU4342643 001 86 DT. 27.03.2024 F2245200641 3 DT. 28.03.2024 F22452006410 DT. 28.03.2024 F22452006412 DT. 28.03.2024 F22452006401 D T. 28.03.2024 S/BILL NO: 8717 970 DT 28-MAR-2024 S/BILL NO: 8718032 DT 28-MAR-2024 S/BIL L NO: 8717979 DT 28-MAR-2024 MNBU4342643 001 S/BILL NO: 8718030 DT 28-MAR-2 024 S/BILL NO: 8718031 DT 28- MAR-2024 S/BILL NO: 8717940 D T 28-MAR-2024 S/BILL NO: 8717 939 DT 28-MAR-2024 NET WT. 94 10.872 KGS 09 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK P MNBU4342643 001 HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERL AND NOTIFY PARTY:4 CURIST C/ O BAKER INDUSTRIES 184 PENNSY MNBU4342643 001 LVANIA AVE PENNSYLVANIA MALV ERN USA- 19355 LABELER CODE : 68462:

45 PALLETS 2530 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 40MG 1000 NDC C ODE:68462039710 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR MNBU0240134 001 EAT GASTROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 4 0MG 100 NDC CODE:68462039701 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO .:91672 THERAPEUTICE USE: -T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE OMEPR MNBU0240134 001 AZOLE DR CAP 20MG 1000 NDC CO DE:68462039610 FDA PRODUCT CO DE NO.:62KCF10 HTS NO.3004.9 0.9255 ANDA NO.:91672 THERAP EUTICE USE: -TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE NAPROXEN TAB 500MG 3 0 NDC CODE:68462019030 FDA P MNBU0240134 001 RODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANA LGESIC NAPROXEN TAB 500MG 1 00 NDC CODE:68462019001 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 MNBU0240134 001 ANDA NO.:-78-250 THERAPEUTIC E USE:-ANTI-INFLAMMATORY, AN ALGESIC CLINDAMYCIN PHOS GE L 1% 60GM NDC CODE:6846208666 5 FDA PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49 .00.50 ANDA NO.:214251 THERA PEUTICE USE: CLINDAMYCIN PHOS MNBU0240134 001 PHATE GEL IS INDICATED IN THE TREATMENT OF ACNE VULGARIS ONDANSETRON ODT 8MG 30UD N DC CODE:68462015813 FDA PRODU CT CODE.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO .:-78-152 THERAPEUTICE USE:-A NTI -EMETIC COMMERCIAL & C MNBU0240134 001 USTOM INVOICE NO. F2245200635 4 DT. 25.03.2024 F22452006355 DT. 25.03.2024 F22452006356 DT. 25.03.2024 F22452006357 D T. 25.03.2024 F22452006353 DT . 25.03.2024 F22452006363 DT. 26.03.2024 S/BILL NO: 864281 6 DT 26-MAR-2024 S/BILL NO: 8 MNBU0240134 001 641238 DT 26-MAR-2024 S/BILL NO: 8641239 DT 26-MAR-2024 S/ BILL NO: 8641237 DT 26-MAR-202 4 S/BILL NO: 8644473 DT 26-MA R-2024 S/BILL NO: 8642841 DT 26-MAR-2024 NET WT. 7499.071 KGS 02 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +20 MNBU0240134 001 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA

44 PALLETS 1900 CARTONS PH ARMACEUTICALS AS UNDER VIOR ELE TAB 0.15/0.02-0.01MG 84 N DC CODE:68462031829 FDA PRODU CT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE MNBU0579750 001 : - ORAL CONTRACEPTIVES NO RETH ACE/EE TAB 1MG/5MCG 90 N DC CODE:68462065790 FDA PRODU CT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE : - TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS D MNBU0579750 001 UE TO MENOPAUSE; OSTEOPOROSIS PREVENTION NAPROXEN TAB 50 0MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAP EUTICE USE:-ANTI-INFLAMMATORY , ANALGESIC GABAPENTIN TAB MNBU0579750 001 800MG 500 NDC CODE:684620127 05 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT GABA PENTIN TAB 800MG 500 NDC CODE :68462012705 FDA PRODUCT COD E:NO : 61 N C A 69 HTS NO.300 MNBU0579750 001 4.90.9236 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULSA NT COMMERCIAL & CUSTOM INVO ICE NO. F22452006392 DT. 27.0 3.2024 F22452006371 DT. 27.03 .2024 F22452006373 DT. 27.03. 2024 F22452006384 DT. 27.03.2 024 S/BILL NO: 8700101 DT 28- MNBU0579750 001 MAR-2024 S/BILL NO: 8700874 D T 28-MAR-2024 S/BILL NO: 8714 651 DT 28-MAR-2024 S/BILL NO: 8715794 DT 28-MAR-2024 NET W T. 8283.895 KGS 02 DATA LOG GERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 MNBU0579750 001 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

39 PALLETS 2365 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 20MG 1000 NDC C ODE:68462039610 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR MNBU0457773 001 EAT GASTROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 4 0MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO. :91672 THERAPEUTICE USE: -TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE ONDANS MNBU0457773 001 ETRON ODT 8MG 30UD NDC CODE:6 8462015813 FDA PRODUCT CODE.: -61 T C A 26 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-152 THERAPEUTICE USE:-ANTI -EME TIC TROSPIUM CL TAB 20MG 60 NDC CODE:68462046160 FDA PR ODUCT CODE NO.:-61 K C A 69 MNBU0457773 001 H. T. S NO.: 3004.49.00.70 A NDA NO.:-91-575 THERAPEUTICE USE:- TREATMENT OF VENOUS DI SEASES URINARY INCONTINENCE THERAPY GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 F DA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA MNBU0457773 001 NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT MARLISSA TAB 0.15/0.03MG 84 NDC CODE:6 8462038829 FDA PRODUCT CODE N O.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 0914 52 THERAPEUTICE USE: ORAL CO NTRACEPTIVE COMMERCIAL & CU MNBU0457773 001 STOM INVOICE NO. F22452006327 DT. 24.03.2024 F22452006328 DT. 24.03.2024 F22452006310 D T. 23.03.2024 S/BILL NO: 8615 589 DT 25-MAR-2024 S/BILL NO: 8615426 DT 25-MAR-2024 S/BIL L NO: 8615425 DT 25-MAR-2024 NET WT.5979.660 KGS 02 DATA MNBU0457773 001 LOGGERS SET TEMPERATURE : + 20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA

CARGO DESCRIPTION, HS CODE AN D AGENT ADDRESS. 23 PALLETS 1861 CARTONS PHARMACEUTICALS AS UNDER OXCARBAZEPINE TAB 30 0MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 AN MNBU0427254 001 DA NO.:-77-802 THERAPEUTICE U SE:-ANTI CONVULSANT AGENT ON DANSETRON ODT 8MG 10UD NDC CO DE:68462015811 FDA PRODUCT CO DE NO.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-152 THERAPEUTICE USE:-ANT I -EMETIC TROSPIUM CL TAB 20 MNBU0427254 001 MG 60 NDC CODE:68462046160 F DA PRODUCT CODE NO.:-61 K C A 69 H. T. S NO.: 3004.49.00. 70 ANDA NO.:-91-575 THERAPEU TICE USE:- TREATMENT OF VENOU S DISEASES URINARY INCONTINE NCE THERAPY OXCARBAZEPINE TA B 300MG 100 NDC CODE:68462013 MNBU0427254 001 801 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO.:-77-802 THERAPEUTI CE USE:-ANTI CONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22452006290 DT. 22.03.20 24 F22452006293 DT. 23.03.202 4 S/BILL NO: 8587864 DT 23-MA MNBU0427254 001 R-2024 S/BILL NO: 8587491 DT 23-MAR-2024 NET WT.3971.970 K GS 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA CLAUSES - NEW AGENT AT MNBU0427254 001 DESTINATION: MAERSK INC. 2 G IRALDA FARMS MADISON AVENUE P.O. BOX 880 07940-0880 MADI SON, NJ USA PHONE: CUSTOMER SERVICE 1 (800) 321-8807 GIR ALDA FARMS (NY/NJ) 1 (973) 514 -5000 BALTIMORE 1 (800) 854-6 553 BOSTON 1 (800) 854-6553 MNBU0427254 001 PHILADELPHIA 1 (800) 854-6553 ROCHESTER 1 (800) 854-6553 F AX: GIRALDA FARMS (NY/NJ) 1 ( 973) 514-5410 BALTIMORE 1 (88 8) 249-8016 BOSTON 1 (866) 34 5-8986 PHILADELPHIA 1 (888) 2 49-8016

42 PALLETS 2227 CARTONS PH ARMACEUTICALS AS UNDER RANO LAZINE ER TAB 500MG 60 NDC CO DE:68462031960 FDA PRODUCT CO DE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.: 211082 THERAPEUTIC USE: - IT MNBU3754230 001 IS AN ANTI-ANGINAL MEDICATIO N. IT WORKS BY IMPROVING BLOO D FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CH EST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) A TTACK OF ANGINA EZETIMIBE- MNBU3754230 001 SIMVA TAB 10/80MG 30 NDC CODE :68462032430 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO .: 3004.49.00.10 ANDA NO.: 2 08699 THERAPEUTICE USE: - THI S COMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLES TEROL AND FATS (SUCH AS LDL, MNBU3754230 001 TRIGLYCERIDES) AND RAISE GOO D CHOLESTEROL (HDL) IN THE BL OOD. EZETIMIBE WORKS BY REDUC ING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "S TATINS." IT WORKS BY REDUCING MNBU3754230 001 THE AMOUNT OF CHOLESTEROL M ADE BY THE LIVER. CARVEDILO L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 HTS NO.3004.90.92 21 ANDA NO.78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST RANOLAZINE ER T MNBU3754230 001 AB 500MG 60 NDC CODE:68462031 960 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004. 49.00.10 ANDA NO.:211082 THE RAPEUTIC USE: - IT IS AN ANTI -ANGINAL MEDICATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFI MNBU3754230 001 CIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN A CUTE (EMERGENCY) ATTACK OF A NGINA CARVEDILOL TAB 25MG 5 00 NDC CODE:68462016505 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO. MNBU3754230 001 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 25MG 100 ND C CODE:68462016501 FDA PRODUC T CODE NO :62 O C A 22 HTS N O.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST TER MNBU3754230 001 IFLUNOMIDE TAB 7MG 30 NDC COD E:68462042330 FDA PRODUCT COD E NO.: 60 L C A 99 H. T. S NO.:3004.90.9215 ANDA NO.: 20 9663 THERAPEUTICE USE: :#MUL TIPLE SCLEROSIS AGENT TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO MNBU3754230 001 DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). SIROLIMUS TAB 1MG MNBU3754230 001 100 NDC CODE:68462068301 FD A PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.92.1 5 ANDA NO.: 208691 THERAPEUT ICE USE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. AP REPITANT CAP 40MG 1UD NDC COD E:68462058340 FDA PRODUCT COD MNBU3754230 001 E NO.: 61 T C E 32 H. T. S N O.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: -AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A MNBU3754230 001 LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT COMMERCIAL & CUSTOM INVOICE NO. F22487002342 DT. 20.03.2 024 F22487002345 DT. 21.03.20 MNBU3754230 001 24 F22487002346 DT. 21.03.202 4 F22487002347 DT. 21.03.2024 F22487002348 DT. 21.03.2024 S/BILL NO: 4004831 DT: 21/03/ 2024 S/BILL NO: 4004832 DT: 2 1/03/2024 S/BILL NO: 4004833 DT: 21/03/2024 S/BILL NO: 400 4834 DT: 21/03/2024 S/BILL NO MNBU3754230 001 : 4004835 DT: 21/03/2024 GROS S WT. 10,515.652 NET WT.7695 .876 13 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 G MNBU3754230 001 LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND

PHARMACEUTICALS AS UNDER NORETHINDRONE TAB 0.35MG 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.6 0.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. LEVONORGESTREL/EE TAB 0.09/0.02MG 84 NDC CODE:68462063729 FD A PRODUCT CODE NO.: 64 G D A 29 H. T. S NO. HLBU9598080 001 : 3006.60.0000 ANDA NO.: 202791 THERAPEUTI CE USE: - : USED FOR PREVENTING PREGNANCY ATOMOXETINE CAP 80MG 30 NDC CODE:684620270 30 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.:3004.90.92.90 ANDA NO.: 079019 THERAP EUTICE USE: - ATOMOXETINE IS USED TO TREAT ATTENTION-DEFICIT HYPERACTIVITY DISORDER (A DHD) AS PART OF A TOTAL TREATMENT PLAN, INCL HLBU9598080 001 UDING PSYCHOLOGICAL, SOCIAL, AND OTHER TREA TMENTS OXCARBAZEPINE TAB 300MG 100 NDC CO DE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT OXCARBAZEPINE TAB 300MG 100 NDC CODE:6846201 3801 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO.:-77-802 THERAPEUT HLBU9598080 001 ICE USE:-ANTI CONVULSANT AGENT 02 DAT A LOGGERS HUMIDITY:65% SET TEMPERATURE : +2 0 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES CONTAINER NO. HLBU9598080 COMMERCIAL & CUSTOM INVOICE NO. F224520 06149 DT. 15.03.2024 F22452006162 DT. 15.03. 2024 F22452006170 DT. 16.03.2024 F224520061 71 DT. 16.03.2024

HEATHER TAB 0.35MG 84 1952 CARTONS PHARMACEUTICALS AS UNDER HEATHER TAB 0.35MG 84 NDC CODE 68462030329 FDA PRODUCT CODE NO. HLBU9704643 001 65 J C A 24 H. T. S NO. 3006.60.00.00 ANDA NO. 90-454 THERAPEUTICE USE PREVENTION OF PREGNANCY. LEVONORGESTREL/EE TAB 0.09/0.02MG 84 HLBU9704643 001 NDC CODE 68462063729 FDA PRODUCT CODE NO. 64 G D A 29 H. T. S NO. 3006.60.0000 ANDA NO. 202791 THERAPEUTICE USE - USED FOR PREVENTING HLBU9704643 001 PREGNANCY NORGEST/EE TAB .18,. 215,.25/.035MG 84 NDC CODE 68462056529 FDA PRODUCT CODE NO. 65 J D A 27 H. T. S NO. 3006.60.00.00 HLBU9704643 001 ANDA NO. 200494 THERAPEUTICE USE - ORAL CONTRACEPTIVES COMMERCIAL & CUSTOM INVOICE NO. F22452006262 DT. 21.03.2024 F22452006263 DT. 21.03.2024 F22452006271 DT. 21.03.2024 HLBU9704643 001 S/BILL NO 8532810 DT 21-MAR-2024 S/BILL NO 8532812 DT 21-MAR-2024 S/BILL NO 8532811 DT 21-MAR-2024 GROSS WT. 6,538.300 NET WT.4830.980 HLBU9704643 001 HBL NO BOM0062454 SCAC CODE YASV 02 DATA LOGGERS HUMIDITY 65%

ROSUVASTATIN TAB 40MG 30 12 PACKAGES 1743 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 40MG 30 NDC CODE 68462026430 FDA PRODUCT CODE HLBU9549362 001 NDC CODE 68462034690 FDA PRODUCT CODE NO. 61 X C A 51 H. T. S NO. 3004.90.91.80 ANDA NO. 90385 THERAPEUTICE USE TREATMENT OF CHRONIC HLBU9549362 001 IDIOPATHIC URTICARIA ZONISAMIDE CAP 50MG 100 NDC CODE 68462012901 FDA PRODUCT CODE NO. -61 M C E 44 H. T. S NO. 3004.49.00.20 ANDA NO. -77-651 HLBU9549362 001 THERAPEUTICE USE -ANTISEIZURE DRUG GABAPENTIN TAB 600MG 500 NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69 HTS NO.3004.90.9236 ANDA NO. -77-662 HLBU9549362 001 THERAPEUTICE USE -ANTICONVULSANT OXCARBAZEPINE TAB 300MG 100 NDC CODE 68462013801 FDA PRODUCT CODE NO. -61 M C A 45 HTS NO.3004.90.9236 ANDA NO. -77-802 HLBU9549362 001 THERAPEUTICE USE -ANTI CONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22452006228 DT. 19.03.2024 F22452006230 DT. 19.03.2024 F22452006245 DT. 20.03.2024 S/BILL NO 8487653 HLBU9549362 001 DT 20-MAR-2024 S/BILL NO 8499760 DT 21-MAR-2024 S/BILL NO 8516569 DT 21-MAR-24 GROSS WT. 10,054.130 NET WT.8739.980 SCSC CODE YASV HLBU9549362 001 HBL NO BOM0062467 02 DATA LOGGERS HLBU9549362 002 NO. 61 J C A 16 H. T. S NO. 3004.49.00.10 ANDA NO. 079172 THERAPEUTICE USE - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT HLBU9549362 002 CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 5MG 90 NDC CODE 68462026190 FDA PRODUCT CODE NO. 61 J C A 16 H. T. S NO. 3004.49.00.10 ANDA NO. 079172 HLBU9549362 002 THERAPEUTICE USE - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 5MG 90 NDC CODE 68462026190 FDA PRODUCT CODE HLBU9549362 002 NO. 61 J C A 16 H. T. S NO. 3004.49.00.10 ANDA NO. 079172 THERAPEUTICE USE - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT HLBU9549362 002 CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22452006250 DT. 20.03.2024 F22452006255 DT. 21.03.2024 F22452006256 DT. 21.03.2024 S/BILL NO 8516621 DT 21-MAR-2024 HLBU9549362 002 S/BILL NO 8516570 DT 21-MAR-2024 S/BILL NO 8516572 DT 21-MAR-2024 SCAC CODE YASV HBL NO BOM0062455 GROSS WT. 3,037.594 NET WT.2,305.97 HLBU9549362 002 12 DATA LOGGERS

PHARMACEUTICALS AS UNDER NORETHINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUC T CODE NO.65 J C A 25 H. T. S NO.: 3004.39 .00.50 ANDA NO.:-91-090 THERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMETRIOS IS AND AB NORMAL UTERINE BLEEDING GABAPENTIN TAB 80 0MG 500 NDC CODE:68462012705 FDA PRODUCT C HLBU9720330 001 ODE:NO : 61 N C A 69 HTS NO.3004.90.9236 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVUL SANT TOPIRAMATE TAB 50MG 500 NDC CODE:684 62015305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT ROPINI ROLE TAB 0.25MG 100 NDC CODE:68462025301 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO. HLBU9720330 001 : 3004.90.92.40 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKINSONISM ROPI NIROLE TAB 0.5MG 100 NDC CODE:68462025401 F DA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPE UTICE USE:-TREATMENT OF PARKINSONISM ROP INIROLE TAB 4MG 100 NDC CODE:68462025801 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO. HLBU9720330 001 : 3004.90.92.40 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKINSONISM 09 DATA LOGGERS HUMIDITY:65% SET TEMPERATU RE : +20 DEGREES TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES CONTAINER NO. HLBU97203 30 COMMERCIAL & CUSTOM INVOICE NO. F22452006082 DT. 12.03.2024 F22452006101 DT. 13.03.2024 F22452006102 DT. 13.03.2024 F22 HLBU9720330 001 452006103 DT. 13.03.2024

PHARMACEUTICALS AS UNDER TELMISARTAN TAB 2 0MG 30 NDC CODE:68462019930 FDA PRODUCT COD E NO.: 62 O C A 09 H. T. S NO.: 3004.90.92 .20 ANDA NO.:090032 THERAPEUTICE USE: INDI CATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE OMEPRAZOLE DR CAP 4 0MG 90 NDC CODE:68462039790 FDA PRODUCT COD HLBU9776514 001 E NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO. :91672 THERAPEUTICE USE: -TREATMENT OF TREA T GASTROESOPHAGEAL REFLUX DISEASE NORETH ACE/EE TAB 1/0.02MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.:206969 THERAPE UTICE USE: - SECONDARY AMENORRHEA,ENDOMETRI OS IS AND ABNORMAL UTERINE BLEEDING HLBU9776514 001 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES CONTAINER NO. HLBU9776514 COMMERCIAL & CUSTOM INV OICE NO. F22452006027 DT. 09.03.2024 F22452 006031 DT. 09.03.2024

TACROLIMUS OINT 2994 CARTONS PHARMACEUTICALS AS UNDER TACROLIMUS OINT 0.1% 30GM NDC CODE 68462053435 FDA PRODUCT CODE NO. 64 T C J 08 HLBU9826507 001 H. T. S NO. 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF HLBU9826507 001 MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 30GM NDC CODE 68462053435 FDA PRODUCT CODE NO. 64 T C J 08 H. T. S NO. HLBU9826507 001 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE HLBU9826507 001 ATOPIC DERMATITIS (ECZEMA). EZETIMIBE TAB 10MG 500 NDC CODE 68462022605 FDA PRODUCT CODE NO. 61 J C A 15 H. T. S NO. 3004.49.00.10 HLBU9826507 001 ANDA NO. 078560 THERAPEUTICE USE LIPID LOWERING AGENT DILTIAZEM HCL ER CAP 12HR 90MG 100 NDC CODE 68462085101 62 O C B 24 3004.49.00.10 HLBU9826507 001 212317 FOR THE TREATMENT OF HYPERTENSION. EZETIMIBE TAB 10MG 90 NDC CODE 68462022690 FDA PRODUCT CODE NO. 61 J C A 15 H. T. S NO. HLBU9826507 001 3004.49.00.10 ANDA NO. 078560 THERAPEUTICE USE LIPID LOWERING AGENT EZETIMIBE-SIMVA TAB 10/20MG 90 NDC CODE 68462032290 FDA PRODUCT CODE NO. 61 J D C 15 HLBU9826507 001 H. T. S NO. 3004.49.00.10 ANDA NO. 208699 THERAPEUTICE USE LIPID LOWERING AGENT TACROLIMUS OINT 0.1% 30GM NDC CODE 68462053435 FDA PRODUCT CODE NO. HLBU9826507 001 64 T C J 08 H. T. S NO. 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE HLBU9826507 001 TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). EZETIMIBE TAB 10MG 90 NDC CODE 68462022690 FDA PRODUCT CODE NO. 61 J C A 15 HLBU9826507 001 H. T. S NO. 3004.49.00.10 ANDA NO. 078560 THERAPEUTICE USE LIPID LOWERING AGENT

PHARMACEUTICALS AS UNDER HEATHER TAB 0.35M G 84 NDC CODE:68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.0 0 ANDA NO.:90-454 THERAPEUTICE USE: PREVEN TION OF PREGNANCY. NORETH ACE/EE TAB 1/0.0 2MG 63 NDC CODE:68462013281 FDA PRODUCT COD E NO.:65 J C A 25 H. T. S NO.: 3006.60.00. HLBU9694355 001 00 ANDA NO.:206969 THERAPEUTICE USE: - SEC ONDARY AMENORRHEA,ENDOMETRIOS IS AND ABNORM AL UTERINE BLEEDING TELMISARTAN TAB 20MG 90 NDC CODE:68462019990 NDC NO.: 6846201999 0 FDA PRODUCT CODE NO :62 O C A 09 HTS NO : 3004.90.92.20 ANDA NO.90032 THERAPEUTICE USE:-INDICATED FOR THE TREATMENT OF HYPERT ENSION, TO LOWER BLOOD PRESSURE OMEPRAZOL HLBU9694355 001 E DR CAP 20MG 1000 NDC CODE:68462039610 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.92 55 ANDA NO.:91672 THERAPEUTICE USE: -TREAT MENT OF TREAT GASTROESOPHAGEAL REFLUX DISEA SE OMEPRAZOLE DR CAP 40MG 90 NDC CODE:684 62039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL HLBU9694355 001 REFLUX DISEASE 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES TO +25 DEGREES CONTAINER NO. HLBU9694355 COMMERCIAL & CUSTOM INVOICE NO. F22452006037 DT. 09.03.20 24 F22452006038 DT. 09.03.2024

ROSUVASTATIN 678 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 20MG 90 NDC CODE 68462026390 FDA PRODUCT CODE NO. 61 J C A 16 HLBU9153432 001 FDA PRODUCT CODE NO 61 W C J 04 HTS NO.3004.90.9240 ANDA NO.90-219 THERAPEUTICE USE -TREATMENT OF CANDIDIASIS CLOTRIMAZOLE CREAM HLBU9153432 001 1% 45GM NDC CODE 68462018147 FDA PRODUCT CODE NO 61 W C J 04 HTS NO.3004.90.9240 ANDA NO.90-219 THERAPEUTICE USE -TREATMENT OF HLBU9153432 001 CANDIDIASIS OMEPRAZOLE DR CAP 20MG 1000 NDC CODE 68462039610 FDA PRODUCT CODE NO. 62KCF10 HTS NO.3004.90.9255 ANDA NO. 91672 HLBU9153432 001 THERAPEUTICE USE -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE LITHIUM CARB CAP 600MG 100 NDC CODE 68462022201 FDA PRODUCT CODE NO. -61 N C E 37 HLBU9153432 001 H. T. S NO. 3004.49.00.20 ANDA NO. - 79 -139 THERAPEUTICE USE -ANTIMANIC AGENT TELMISARTAN TAB 20MG 90 NDC CODE 68462019990 NDC NO. 68462019990 HLBU9153432 001 FDA PRODUCT CODE NO 62 O C A 09 HTS NO 3004.90.92.20 ANDA NO.90032 THERAPEUTICE USE -INDICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER HLBU9153432 001 BLOOD PRESSURE PRAMIPEXOLE TAB 1MG 90 NDC CODE 68462033390 FDA PRODUCT CODE NO. 62 J C A 15 H. T. S NO. 3004.90.92.40 ANDA NO. 90-781 HLBU9153432 001 THERAPEUTICE USE USED IN PARKINSONS DISEASE OMEPRAZOLE DR CAP 20MG 1000 NDC CODE 68462039610 FDA PRODUCT CODE NO. 62KCF10 HTS NO.3004.90.9255 HLBU9153432 001 ANDA NO. 91672 THERAPEUTICE USE -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22452006056 DT. 11.03.2024 HLBU9153432 001 F22452006051 DT. 11.03.2024 F22452006052 DT. 11.03.2024 F22452006055 DT. 11.03.2024 F22452006066 DT. 11.03.2024 S/BILL NO 8225460 DT 11-MAR-2024 S/BILL NO 8219780 DT 11-MAR-2024 HLBU9153432 001 S/BILL NO 8227053 DT 11-MAR-2024 XX CARGO DESCRIPTION XX HLBU9153432 002 H. T. S NO. 3004.49.00.10 ANDA NO. 079172 THERAPEUTICE USE - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE HLBU9153432 002 COMMERCIAL & CUSTOM INVOICE NO. F22452006053 DT. 11.03.2024 S/BILL NO 8225451 DT 11-MAR-2024 SCAC CODE YASV HBL NO BOM0062303 GROSS WT. 1,598.540 HLBU9153432 002 NET WT.1,259.44 06 DATA LOGGERS HUMIDITY 65%

NORETHINDRONE TAB 0.35MG 84 2733 CARTONS PHARMACEUTICALS AS UNDER NORETHINDRONE TAB 0.35MG 84 NDC CODE 68462030529 FDA PRODUCT CODE NO. 65 J C A 26 HLBU9876200 001 H. T. S NO. 3006.60.00.00 ANDA NO. 91-209 THERAPEUTICE USE PREVENTION OF PREGNANCY. TOPIRAMATE TAB 50MG 500 NDC CODE 68462015305 FDA PRODUCT CODE NO. HLBU9876200 001 61 M C A 40 H. T. S NO. 3004.49.00.20 ANDA NO. 077627 THERAPEUTICE USE ANTICONVULSANT PRAMIPEXOLE TAB 0.25MG 90 NDC CODE 68462033190 HLBU9876200 001 FDA PRODUCT CODE NO. 62 J C A 15 H. T. S NO. 3004.90.92.40 ANDA NO. 90-781 THERAPEUTICE USE USED IN PARKINSONS DISEASE PRAMIPEXOLE TAB 1MG 90 HLBU9876200 001 NDC CODE 68462033390 FDA PRODUCT CODE NO. 62 J C A 15 H. T. S NO. 3004.90.92.40 ANDA NO. 90-781 THERAPEUTICE USE USED IN PARKINSONS DISEASE HLBU9876200 001 OMEPRAZOLE DR CAP 20MG 1000 NDC CODE 68462039610 FDA PRODUCT CODE NO. 62KCF10 HTS NO.3004.90.9255 ANDA NO. 91672 THERAPEUTICE USE -TREATMENT OF TREAT HLBU9876200 001 GASTROESOPHAGEAL REFLUX DISEASE LITHIUM CARB CAP 150MG 100 NDC CODE 68462022001 FDA PRODUCT CODE NO. -61 N C E 37 H. T. S NO. 3004.49.00.20 HLBU9876200 001 ANDA NO. - 79 -139 THERAPEUTICE USE -ANTIMANIC AGENT CLOTRIMAZOLE CREAM 1% 30GM NDC CODE 68462018135 FDA PRODUCT CODE NO 61 W C J 04 HTS NO.3004.90.9240 HLBU9876200 001 ANDA NO.90-219 THERAPEUTICE USE -TREATMENT OF CANDIDIASIS COMMERCIAL & CUSTOM INVOICE NO. F22452006078 DT. 12.03.2024 F22452006079 DT. 12.03.2024 HLBU9876200 001 F22452006080 DT. 12.03.2024 F22452006081 DT. 12.03.2024 S/BILL NO 8247950 DT 12-MAR-2024 S/BILL NO 8253100 DT 12-MAR-2024 S/BILL NO 8253106 DT 12-MAR-2024 HLBU9876200 001 S/BILL NO 8253105 DT 12-MAR-2024 SCAC CODE YASV HBL NO BOM0062305 GROSS WT. 9,290.493 NET WT.7389.558 NET WT. 7389.558 KGS 02 DATA LOGGERS HLBU9876200 001 HUMIDITY 65% XXCARGO DESCRIPTION XX

TACROLIMUS OINT 0.1% 488 CARTONS PHARMACEUTICALS AS UNDER TACROLIMUS OINT 0.1% 100GM NDC CODE 68462053494 HLBU9783370 001 FDA PRODUCT CODE NO. 62KCF10 HTS NO.3004.90.9255 ANDA NO. 91672 THERAPEUTICE USE -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE HLBU9783370 001 VERAPAMIL HCL ER TAB 120MG 100 NDC CODE 68462029201 NDC NO. 68462029201 FDA PRODUCT CODE NO. 62 O C B 13 HTS NO.3004.90.9221 ANDA NO. 090700 HLBU9783370 001 THERAPEUTICE USE --ANGINA TOPIRAMATE TAB 25MG 500 NDC CODE 68462010805 FDA PRODUCT CODE NO. 61 M C A 40 H. T. S NO. 3004.49.00.20 HLBU9783370 001 ANDA NO. 077627 THERAPEUTICE USE ANTICONVULSANT TOPIRAMATE TAB 25MG 60 NDC CODE 68462010860 FDA PRODUCT CODE NO. -61 M C A 40 H. T. S NO. HLBU9783370 001 3004.49.00.20 ANDA NO. - 77-627 THERAPEUTICE USE -ANTICONVULSANT LITHIUM CARB ER TAB 450MG 100 NDC CODE 68462022401 FDA PRODUCT CODE NO. 61 N C B 37 HLBU9783370 001 H. T. S NO. 3004.49.00.20 ANDA NO. 91-616 THERAPEUTICE USE - INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER. HLBU9783370 001 BIPOLAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, IN THE OLDER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS HLBU9783370 001 WITH A DIAGNOSIS OF BIPOLAR DISORDER. MAINTENANCE THERAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH HLBU9783370 001 MAY OCCUR. COMMERCIAL & CUSTOM INVOICE NO. F22452005990 DT. 06.03.2024 F22452005993 DT. 06.03.2024 F22452005991 DT. 06.03.2024 S/BILL NO 8133429 DT 07-MAR-2024 HLBU9783370 001 S/BILL NO 8133390 DT 07-MAR-2024 S/BILL NO 8133392 DT 07-MAR-2024 SCAC CODE YASV HBL NO BOM0062162 GROSS WT. 5,154.364 KGS NET WT.4092.619 KGS HLBU9783370 001 11 DATA LOGGERS HUMIDITY 65% HLBU9783370 002 FDA PRODUCT CODE NO. 64 T C J 08 H. T. S NO. 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE HLBU9783370 002 OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 60GM NDC CODE 68462053465 HLBU9783370 002 FDA PRODUCT CODE NO. 64 T C J 08 H. T. S NO. 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE HLBU9783370 002 OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). PIMECROLIMUS CREAM 1% 30GM NDC CODE 68462060935 HLBU9783370 002 FDA PRODUCT CODE NO. 61 S C J 04 H. T. S NO. 3004.90.92.45 ANDA NO. 211769 THERAPEUTICE USE - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND HLBU9783370 002 NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE HLBU9783370 002 PIMECROLIMUS CREAM 1% 60GM NDC CODE 68462060965 FDA PRODUCT CODE NO. 61 S C J 04 H. T. S NO. 3004.90.92.45 ANDA NO. 211769 HLBU9783370 002 THERAPEUTICE USE - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- HLBU9783370 002 IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE TACROLIMUS OINTMENT 0.03% 30GM NDC CODE 68462088135 FDA PRODUCT CODE NO. 64 T C J 08 HLBU9783370 002 H. T. S NO. 3004.49.0050 ANDA NO. 210393 THERAPEUTICE USE TOPICAL IMMUNOSUPPRESSIVE AGENT COMMERCIAL & HLBU9783370 002 CUSTOM INVOICE NO. F22487002228 DT. 29.02.2024 SCAC CODE YASV HBL NO BOM0062163 XX CARGO DESCRIPTION XX

NORETH ACE/EE TAB 1MG/5MCG 3166 CARTONS PHARMACEUTICALS AS UNDER NORETH ACE/EE TAB 1MG/5MCG 84 NDC CODE 68462065729 FDA PRODUCT CODE NO. HLBU9295669 001 65 J D A 25 H. T. S NO. 3006.60.00.00 ANDA NO. 203038 THERAPEUTICE USE - TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS HLBU9295669 001 DUE TO MENOPAUSE; OSTEOPOROSIS PREVENTION GABAPENTIN TAB 600MG 500 NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69 HTS NO.3004.90.9236 ANDA NO. -77-662 HLBU9295669 001 THERAPEUTICE USE -ANTICONVULSANT TOPIRAMATE TAB 25MG 60 NDC CODE 68462010860 FDA PRODUCT CODE NO. -61 M C A 40 H. T. S NO. 3004.49.00.20 HLBU9295669 001 ANDA NO. - 77-627 THERAPEUTICE USE -ANTICONVULSANT ROPINIROLE TAB 0.25MG 100 NDC CODE 68462025301 FDA PRODUCT CODE NO. -62 J C A 17 H. T. S NO. HLBU9295669 001 3004.90.92.40 ANDA NO. - 90-135 THERAPEUTICE USE -TREATMENT OF PARKINSONISM ROPINIROLE TAB 2MG 100 NDC CODE 68462025601 FDA PRODUCT CODE HLBU9295669 001 NO. -62 J C A 17 H. T. S NO. 3004.90.92.40 ANDA NO. - 90-135 THERAPEUTICE USE -TREATMENT OF PARKINSONISM COMMERCIAL & HLBU9295669 001 CUSTOM INVOICE NO. F22452006005 DT. 07.03.2024 F22452006007 DT. 07.03.2024 F22452006008 DT. 07.03.2024 S/BILL NO 8168682 DT 08-MAR-2024 S/BILL NO 8167891 DT 08-MAR-2024 S/BILL NO 8169182 DT 08-MAR-2024 SCAC CODE YASV HLBU9295669 001 HBL NO BOM0062171 GROSS WT. 11,809.551 KGS NET WT. 10083.032 KGS 02 DATA LOGGERS HUMIDITY 65%

ASPIRIN-ER DIPYRIDAMOLECAP 25/200MG 6 PACKAGES 423 CARTONS PHARMACEUTICALS AS UNDER ASPIRIN-ER DIPYRIDAMOLE CAP 25/200MG 60 NDC CODE 68462040560 HLBU9711175 001 CODE NO 61 N C A 69 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT EZETIMIBE-SIMVA TAB 10/10MG 90 NDC CODE 68462032190 HLBU9711175 001 FDA PRODUCT CODE NO. 61 J D C 15 H. T. S NO. 3004.49.00.10 ANDA NO. 208699 THERAPEUTICE USE - THIS COMBINATION MEDICATION IS USED TO HELP LOWER HLBU9711175 001 BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM HLBU9711175 001 YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "STATINS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER BISOPROLOL-HCTZ TAB 5/6.25MG 30 HLBU9711175 001 NDC CODE 68462087930 FDA PRODUCT CODE NO 62 O D A 18 HTS NO.3004.49.0010 ANDA NO.215995 THERAPEUTICE USE -BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE HLBU9711175 001 TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENSION. GABAPENTIN TAB 600MG 500 NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69 HLBU9711175 001 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT POTASSIUM CL ER CAP 10MEQ 100 NDC CODE 68462035701 FDA PRODUCT CODE NO. 65 R C F 14 HLBU9711175 001 H. T. S NO. 3004.90.92.90 ANDA NO. 202868 THERAPEUTICE USE - TREATMENT OR PREVENTION OF HYPOKALEMIA GABAPENTIN TAB 600MG 500 HLBU9711175 001 NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT METFORMIN HCL ER TAB HLBU9711175 001 (Z) 1000MG 90 NDC CODE 68462052190 FDA PRODUCT CODE NO. 61 P C A 55 H. T. S NO. 3004.90.92.40 ANDA NO. 212969 THERAPEUTICE USE THE HLBU9711175 001 MANAGEMENT OF TYPE 2 DIABETES XX CARGO DESCRIPTION XX HLBU9711175 002 H. T. S NO. 3004.90.92.40 ANDA NO. 212969 THERAPEUTICE USE THE MANAGEMENT OF TYPE 2 DIABETES GABAPENTIN TAB 600MG 500 NDC CODE 68462012605 HLBU9711175 002 FDA PRODUCT CODE NO 61 N C A 69 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT SAXAGLIPTIN TAB 5MG 90 NDC CODE 68462072790 HLBU9711175 002 FDA PRODUCT CODE NO. 61 P C A 99 H. T. S NO. 3004.90.9220 ANDA NO. 205994 THERAPEUTICE USE ANTI-DIABETIC AGENT EZETIMIBE TAB 10MG 500 HLBU9711175 002 NDC CODE 68462022605 FDA PRODUCT CODE NO. 61 J C A 15 H. T. S NO. 3004.49.00.10 ANDA NO. 078560 THERAPEUTICE USE LIPID LOWERING AGENT HLBU9711175 002 TACROLIMUS CAP 1MG 100 NDC CODE 68462068601 HTS NO 3004.90.92.15 FDA CODE 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER HLBU9711175 002 TRANSPLANT SAXAGLIPTIN TAB 5MG 30 NDC CODE 68462072730 FDA PRODUCT CODE NO. 61 P C A 99 H. T. S NO. 3004.90.9220 ANDA NO. 205994 HLBU9711175 002 THERAPEUTICE USE ANTI-DIABETIC AGENT PIMECROLIMUS CREAM 1% 30GM NDC CODE 68462060935 FDA PRODUCT CODE NO. 61 S C J 04 H. T. S NO. HLBU9711175 002 3004.90.92.45 ANDA NO. 211769 THERAPEUTICE USE - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC HLBU9711175 002 DERMATITIS IN NONIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE COMMERCIAL & CUSTOM INVOICE NO. F22487002201 DT. 29.02.2024 F22487002204 DT. 29.02.2024 HLBU9711175 002 F22487002212 DT. 29.02.2024 F22487002213 DT. 29.02.2024 F22487002216 DT. 29.02.2024 F22487002218 DT. 29.02.2024 F22487002220 DT. 29.02.2024 F22487002222 DT. 29.02.2024 F22487002224 DT. 29.02.2024 F22487002226 DT. 29.02.2024 HLBU9711175 002 F22487002231 DT. 29.02.2024 F22487002234 DT. 29.02.2024 F22487002235 DT. 29.02.2024 SCAC CODE YASV HBL NO BOM0062160 HLBU9711175 003 FDA PRODUCT CODE NO. 60 L D F 05 H. T. S NO. 3004.90.9220 ANDA NO. 210318 COMMERCIAL & CUSTOM INVOICE NO. F22487002202 DT. 29.02.2024 HLBU9711175 003 S/BILL NO 4003879 DT 06/03/3034 GROSS WT. 1,376.304 KGS NET WT.423.65 KGS SCAC CODE YASV HBL NO BOM0062161 06 DATA LOGGERS HUMIDITY 65%

4 PACKAGES 121 CARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TAB 40MG 500 NDC CODE 68462026405 61 J C A 16 3004.49.00.10 HLBU9758974 001 61 M C A 38 H. T. S NO. 3004.90.92.30 ANDA NO. -79 099 THERAPEUTICE USE - ANTICONVULSANT OMEPRAZOLE DR CAP 40MG 1000 NDC CODE 68462039710 HLBU9758974 001 FDA PRODUCT CODE NO. 62KCF10 HTS NO.3004.90.9255 ANDA NO. 91672 THERAPEUTICE USE -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE HLBU9758974 001 ATOMOXETINE CAP 60MG 30 NDC CODE 68462026930 FDA PRODUCT CODE NO. 79019 H. T. S NO. 3004.90.92.90 ANDA NO. 079019 THERAPEUTICE USE - HLBU9758974 001 TREATMENT OF ATTENTION - DEFICIT/HYPERACIVITY DISORDER (ADHD VERAPAMIL HCL ER TAB 180MG 100 NDC CODE 68462029301 FDA PRODUCT CODE NO. 62 O C B 13 HLBU9758974 001 HTS NO.3004.90.9221 ANDA NO. 078906 THERAPEUTICE USE --ANGINA VERAPAMIL HCL ER TAB 180MG 500 NDC CODE 68462029305 FDA PRODUCT CODE NO. HLBU9758974 001 62 O C B 13 HTS NO.3004.90.9221 ANDA NO. 078906 THERAPEUTICE USE --ANGINA PRAMIPEXOLE TAB 0.125MG 90 NDC CODE 68462033090 FDA PRODUCT CODE NO. HLBU9758974 001 62 J C A 15 H. T. S NO. 3004.90.92.40 ANDA NO. 90-781 THERAPEUTICE USE USED IN PARKINSONS DISEASE ATOVAQUONE-PROG TAB 62.5/25MG 100 HLBU9758974 001 NDC CODE 68462040201 FDA PRODUCT CODE NO. 62 L D A 44 H. T. S NO. 3004.90.92.90 ANDA NO. 91-211 ANTI MALARIAL COMMERCIAL & HLBU9758974 001 CUSTOM INVOICE NO. F22452005767 DT. 26.02.2024 F22452005773 DT. 27.02.2024 S/BILL NO 7868256 DT 27-FEB-2024 S/BILL NO 7875607 DT 27-FEB-2024 GROSS WT. 9,336.249 KGS HLBU9758974 001 NET WT. 7689.867 KGS SCAC CODE YASV HBL NO BOM0061866 02 DATA LOGGERS HUMIDITY 65% SET TEMPERATURE +20 DEGREES TEMPERATURE RANGE HLBU9758974 001 +15 DEGREES TO +25 DEGREES X A/C GLENMARK PHARMACEUTICALS HLBU9758974 002 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22452005774 DT. 27.02.2024 HLBU9758974 002 S/BILL NO 7868257 DT 27-FEB-2024 GROSS WT. 721.765 KGS NET WT. 641.50 KGS SCAC CODE YASV HBL NO BOM0061868 04 DATA LOGGERS HUMIDITY 65% HLBU9758974 002 SET TEMPERATURE +20 DEGREES TEMPERATURE RANGE +15 DEGREES TO +25 DEGREES

PHARMACEUTICALS AS UNDER TELMISARTAN TAB 8 0MG 30 NDC CODE:68462020130 HTS NO : 3004.9 0.92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90 032 THERAPEUTICE USE : INDICATED FOR THE T REATMENT OF HYPERTENSION, TO LOWER BLOOD PR ESSURE OMEPRAZOLE DR CAP 40MG 1000 NDC CO DE:68462039710 FDA PRODUCT CODE NO.:62KCF10 HLBU9708633 001 HTS NO.3004.90.9255 ANDA NO.:91672 THERAP EUTICE USE: -TREATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 40 MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO.: 91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE 02 DATA LOGGERS HUMIDITY:65% SET TEMPER HLBU9708633 001 ATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES CONTAINER NO. HLBU97 08633 COMMERCIAL & CUSTOM INVOICE NO. F 22452005755 DT. 25.02.2024

CARVEDILOL TAB 12.5MG 500 3220 CARTONS PHARMACEUTICALS AS UNDER CARVEDILOL TAB 12.5MG 500 NDC CODE 68462016405 FDA PRODUCT CODE NO 62 O C A 22 HLBU9326116 001 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE -BETA- ADRENOACEPTOR ANTAGONIST BISOPROLOL-HCTZ TAB 5/6.25MG 100 HLBU9326116 001 NDC CODE 68462087901 FDA PRODUCT CODE NO 62 O D A 18 HTS NO.3004.49.0010 ANDA NO.215995 THERAPEUTICE USE -BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE HLBU9326116 001 TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENSION. EZETIMIBE-SIMVA TAB 10/10MG 30 NDC CODE 68462032130 FDA PRODUCT CODE NO. HLBU9326116 001 61 J D C 15 H. T. S NO. 3004.49.00.10 ANDA NO. 208699 THERAPEUTICE USE - THIS COMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AND HLBU9326116 001 FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN HLBU9326116 001 BELONGS TO A GROUP OF DRUGS KNOWN AS "STATINS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER. INDOMETHACIN ER CAP 75MG 60 NDC CODE 68462032560 FDA PRODUCT CODE 62 HLBU9326116 001 GCE42 H. T. S NO. 3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE INDOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ARTHRITIS, GOUT, BURSITIS, HLBU9326116 001 AND TENDONITIS. IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID). ... HLBU9326116 001 THIS EFFECT HELPS TO DECREASE SWELLING AND PAIN. TACROLIMUS OINT 0.1% 30GM NDC CODE 68462053435 FDA PRODUCT CODE NO. 64 T C J 08 H. T. S NO. HLBU9326116 001 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE HLBU9326116 001 ATOPIC DERMATITIS (ECZEMA). TACROLIMUS CAP 1MG 100 NDC CODE 68462068601 HTS NO 3004.90.92.15 FDA CODE 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE TO HLBU9326116 001 PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSPLANT XX CARGO DESCRIPTION XX